1 / 15

Gonorrhea Sexually Transmitted Disease Surveillance 1998

Gonorrhea Sexually Transmitted Disease Surveillance 1998. Division of STD Prevention. Gonorrhea - Reported rates: United States, 1970-1998 and the Healthy People year 2000 objective. Note: Georgia did not report gonorrhea statistics in 1994.

aideen
Télécharger la présentation

Gonorrhea Sexually Transmitted Disease Surveillance 1998

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GonorrheaSexually Transmitted Disease Surveillance 1998 Division of STD Prevention

  2. Gonorrhea - Reported rates: United States, 1970-1998 and the Healthy People year 2000 objective Note: Georgia did not report gonorrhea statistics in 1994

  3. Gonorrhea - Rates by state: United States and outlying areas, 1998 Note: The total rate of gonorrhea for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 131.1 per 100,000 population. The Healthy People year 2000 objective is 100 per 100,000 population.

  4. Gonorrhea - Rates by region: United States, 1981-1998 and the Healthy People year 2000 objective Note: Georgia did not report gonorrhea statistics in 1994

  5. Gonorrhea - Rates in selected U.S. cities of >200,000 population, 1981-1998 and the Healthy People year 2000 objective Note: Atlanta, GA did not report gonorrhea statistics in 1994

  6. Gonorrhea - Rates by gender: United States, 1981-1998 and the Healthy People year 2000 objective Note: Georgia did not report gonorrhea statistics in 1994

  7. Gonorrhea - Rates by race and ethnicity: United States, 1981-1998 and the Healthy People year 2000 objective Note: "Other" includes Asian/Pacific Islander and American Indian/Alaska Native populations. Black, White, and Other are non-Hispanic. Georgia did not report gonorrhea statistics in 1994

  8. Gonorrhea - Age- and gender-specific rates: United States, 1998

  9. Gonorrhea - Positivity among 15-24 year old women tested in family planning clinics by state, 1998 *States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 1998. SOURCE: Regional Infertility Prevention Programs; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

  10. Gonococcal Isolate Surveillance Project (GISP) - Location of participating clinics and regional laboratories: United States, 1998

  11. Gonococcal Isolate Surveillance Project (GISP) - Trends in plasmid-mediated resistance to penicillin and tetracycline, 1988-1998 Note: "PPNG" (penicillinase-producing Neisseria gonorrhoeae) and "TRNG" (tetracycline- resistant N. gonorrhoeae) refer to plasmid-mediated resistance to penicillin and tetracycline, respectively.

  12. Gonococcal Isolate Surveillance Project (GISP) - Trends in chromosomally mediated resistance to penicillin and tetracycline, 1988-1998 Note: Chromosomally mediated resistance to penicillin denotes a minimum inhibitory concentration (MIC) of greater than or equal to 2 g penicillin/mL and beta-lactamase negative; chromosomally mediated resistance to tetracycline corresponds to a MIC of greater than or equal to 2 g tetracycline/mL without plasmid-mediated tetracycline resistance.

  13. Gonococcal Isolate Surveillance Project (GISP) - Prevalence of Neisseria gonorrhoeae with decreased susceptibility or resistance to ciprofloxacin, 1990-1998 Note: Resistant isolates have MICs greater than or equal to 1 g ciprofloxacin/mL. Isolates with decreased susceptibility have MICs of 0.125 - 0.5 g ciprofloxacin/mL. There were twenty three (23) resistant isolates: one in 1991, one in 1993, two in 1994, eight in 1995, two in 1996, five in 1997 and four in 1998. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

  14. Gonococcal Isolate Surveillance Project (GISP) - Proportion of men with gonorrhea who had a previous gonorrhea infection within the past year, 1992-1998 Note: GISP cases with no information on previous episodes of gonorrhea were excluded. Data on previous episodes of gonorrhea were first collected in 1992.

  15. Gonococcal Isolate Surveillance Project (GISP) - Percent of Neisseria gonorrhoeae isolates obtained from men who have sex with men for STD clinics in nine cities, 1994, 1996 and 1998 Note: In 1998, these nine clinics reported 87.3% (439/503) of GISP gonorrhea cases in men who have sex with men. Chicago first participated in 1996. Clinics include: CHI=Chicago, IL; DEN=Denver, CO; HON=Honolulu, HI; LBC=Long Beach, CA; ORA=Orange County, CA; POR=Portland, OR; SDG=San Diego, CA; SEA=Seattle, WA; and SFO=San Francisco, CA.

More Related